Smith, Salley & Associates Elevance Health, Inc. Transaction History
Smith, Salley & Associates
- $1.5 Billion
- Q4 2024
A detailed history of Smith, Salley & Associates transactions in Elevance Health, Inc. stock. As of the latest transaction made, Smith, Salley & Associates holds 29,705 shares of ELV stock, worth $11.6 Million. This represents 0.73% of its overall portfolio holdings.
Number of Shares
29,705
Previous 31,085
4.44%
Holding current value
$11.6 Million
Previous $16.2 Million
32.11%
% of portfolio
0.73%
Previous 1.09%
Shares
7 transactions
Others Institutions Holding ELV
# of Institutions
1,822Shares Held
196MCall Options Held
1.03MPut Options Held
1.24M-
Vanguard Group Inc Valley Forge, PA21.3MShares$8.31 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY20.7MShares$8.06 Billion0.26% of portfolio
-
State Street Corp Boston, MA10.7MShares$4.16 Billion0.23% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10.2MShares$3.95 Billion0.61% of portfolio
-
Geode Capital Management, LLC Boston, MA4.85MShares$1.89 Billion0.21% of portfolio
About Elevance Health, Inc.
- Ticker ELV
- Exchange NYSE
- Sector Healthcare
- Industry Healthcare Plans
- Shares Outstandng 240,000,992
- Market Cap $93.4B
- Description
- Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions....